Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

Borrow R, Carlone GM, Rosenstein N, Blake M, Feavers I, Martin D, Zollinger W, Robbins J, Aaberge I, Granoff DM, Miller E, Plikaytis B, van Alphen L, Poolman J, Rappuoli R, Danzig L, Hackell J, Danve B, Caulfield M, Lambert S, Stephens D.

Vaccine. 2006 Jun 12;24(24):5093-107. No abstract available.

PMID:
16838413
2.

Neisseria meningitidis serogroup B: laboratory correlates of protection.

Vermont C, van den Dobbelsteen G.

FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):89-96. Review.

3.

[Active immunization against serogroup B Neisseria meningitidis].

Navarro-Alonso JA.

Enferm Infecc Microbiol Clin. 2003 Nov;21(9):513-9. Review. Spanish.

PMID:
14572386
4.

Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.

Taha MK, Zarantonelli ML, Alonso JM, Naess LM, Holst J, Feiring B, Rosenqvist E.

Vaccine. 2007 Mar 30;25(14):2537-8. Epub 2006 Jan 20. No abstract available.

PMID:
16460845
5.

Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.

Fukasawa LO, Dias WO, Schenkman RP, Raw I, Tanizaki MM.

FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):205-10.

6.

Meningococcal B vaccine development and evaluation of efficacy.

van Alphen L, van den Dobbelsteen G.

Hum Vaccin. 2008 Mar-Apr;4(2):158-61. Epub 2007 Aug 14.

PMID:
18388494
7.
8.

Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro.

Santos GF, Giuliani M, Santini L, Adu-Bobie J, Pizza M, Rappuoli R, Wacknov W, Donnelly J.

Clin Vaccine Immunol. 2009 Nov;16(11):1693-5. doi: 10.1128/CVI.00125-09. Epub 2009 Aug 26.

9.

An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups.

Pinto VB, Moran EE, Cruz F, Wang XM, Fridman A, Zollinger WD, Przysiecki CT, Burden R.

Vaccine. 2011 Oct 13;29(44):7752-8. doi: 10.1016/j.vaccine.2011.07.124. Epub 2011 Aug 7.

PMID:
21827811
10.

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.

Nøkleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P.

Vaccine. 2007 Apr 20;25(16):3080-4. Epub 2007 Jan 22.

PMID:
17287053
12.

Meningococcal surrogates of protection--serum bactericidal antibody activity.

Borrow R, Balmer P, Miller E.

Vaccine. 2005 Mar 18;23(17-18):2222-7. Review.

PMID:
15755600
13.

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.

Su EL, Snape MD.

Expert Rev Vaccines. 2011 May;10(5):575-88. doi: 10.1586/erv.11.32. Review.

PMID:
21604979
16.

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

Giuliani MM, Biolchi A, Serruto D, Ferlicca F, Vienken K, Oster P, Rappuoli R, Pizza M, Donnelly J.

Vaccine. 2010 Jul 12;28(31):5023-30. doi: 10.1016/j.vaccine.2010.05.014. Epub 2010 May 21.

PMID:
20493284
17.

Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.

Delgado M, Yero D, Niebla O, González S, Climent Y, Pérez Y, Cobas K, Caballero E, García D, Pajón R.

Vaccine. 2007 Dec 5;25(50):8420-31. Epub 2007 Oct 11.

PMID:
17996338
18.

Assessment of vaccine potential of the Neisseria-specific protein NMB0938.

Sardiñas G, Climent Y, Rodríguez Y, González S, García D, Cobas K, Caballero E, Pérez Y, Brookes C, Taylor S, Gorringe A, Delgado M, Pajón R, Yero D.

Vaccine. 2009 Nov 16;27(49):6910-7. doi: 10.1016/j.vaccine.2009.09.005. Epub 2009 Sep 12.

PMID:
19751688
19.

Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.

Pillai S, Howell A, Alexander K, Bentley BE, Jiang HQ, Ambrose K, Zhu D, Zlotnick G.

Vaccine. 2005 Mar 18;23(17-18):2206-9.

PMID:
15755596
20.

[Antigenic activity of oral whole-culture meningococcal serogroup B vaccine].

Aleksakhina NN, Basnak'ian IA, Kozlova NN, Verner IK.

Zh Mikrobiol Epidemiol Immunobiol. 2004 Jul-Aug;(4):35-40. Russian.

PMID:
15481917

Supplemental Content

Support Center